[Successful use of adjuvant immunotherapy in resected colorectal tumors].
Würschmidt
F
F
Baumann
M
M
D000230:Adenocarcinoma / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000920:Antibody-Dependent Cell Cytotoxicity; D015179:Colorectal Neoplasms / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D005500:Follow-Up Studies; D006801:Humans; D016219:Immunotherapy, Adoptive; D013997:Time Factors
D000911:Antibodies, Monoclonal